Search

Competing Interests: Conflicts of interest Dr Bae reported serving on the advisory board for Abbvie outside the submitted work. Dr Mann reported serving as a consultant for Methapharma outside the submitted work. Author Ma; Drs Zafar, Goldman, Munavalli, Zimmet, Nguyen, Mishra, Cartee, Hsu, Silapunt, R.A. Weiss, and M.A. Weiss; Author Haq; Dr Ahmed; Authors Koza, Shi, and Dave; Drs Yi, Kang, Cahn, Kole, Friedmann, Chow, Minkis, Stücker, Schlick, Hoss, Hu, Kibbi, Saikaly, Greywal, Hooper, Vashi, Boucher, Ward, Neuhaus, Ghareeb, Luke, Karen, Suggs, Lucas, Decker, Brieva, Yoo, Suozzi, and Alam have no conflicts of interest to declare.

Pembrolizumab is a humanized IgG4 isotype mAb that the targets and blocks the programmed cell death protein 1 receptor on lymphocytes. Its use in treating metastatic melanoma is associated with increased overall survival compared to other older immunotherapies. Several adverse effects have been noted including both systemic and cutaneous manifestations. As a relatively novel treatment option, many new cutaneous manifestations are still being observed, occurring at various times after initiation of therapy. Previously noted cutaneous adverse effects include sarcoid-like reactions, rash, and changes in preexisting lesions or scars. Here we present a case in which biopsy-proven morphea developed after completion of pembrolizumab therapy., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)

The long-term effects of extracorporeal shockwave lithotripsy (SWL) on the kidneys of children treated for renal calculi are unclear. In order to determine if SWL has any negative effects on renal growth rates, we reviewed long-term (mean 9-year) follow-up data on 29 pediatric patients treated between 1984 and 1988 with an unmodified Dornier HM3 lithotripter. Changes in renal length, serum creatinine, and blood pressure were analyzed. Predicted renal growth was calculated using a formula for age-adjusted renal length. Treated kidneys were stratified into normal and abnormal groups based on a history of renal surgery, evidence of recurrent infection, and obvious anatomic abnormalities. Fifty-six upper urinary tract calculi were treated in 34 renal units. Twenty-two renal units (68%) were rendered stone free, and 65% of the patients continue to be stone free. At follow-up, one patient was classified as having new-onset hypertension, and the mean serum creatinine was 0.93 +/- 0.08 mg/dL. Both at treatment and at follow-up, no significant differences were found in the sizes of the treated and untreated kidneys. However, at treatment, the abnormal group of kidneys seemed to be smaller than expected (mean Z -1.30 +/- 1.10), whereas the group of normal kidneys was very close (mean Z 0.18 +/- 0.54) to the predicted length. At follow-up, the deviations between actual and predicted renal length were significantly more negative. Treated kidneys were an additional 1.26 +/- 0.49 SD units below their expected length (p = 0.02). Untreated kidneys were further below normal as well but possibly to a lesser degree (-0.82 +/- 0.36; p <0.04). Although there was a trend for the abnormal group to have smaller kidneys than the normal group, both groups showed the same trend toward an age-adjusted reduction in renal growth at follow-up. The alterations in renal growth patterns observed in this population are unsettling and could be secondary to either treatment effect (SWL) or, more likely, to some underlying pathology intrinsic to pediatric kidneys with urolithiasis. Until further data are available, SWL in the pediatric population should be applied with caution and at the lowest dosage sufficient to achieve stone comminution.

A minimally invasive approach for urolithiasis patients with complex anatomic abnormalities occasionally necessitates the use of laparoscopic techniques, either alone or in combination with endourologic techniques. The management of these patients is best accomplished in centers with the facilities to provide a spectrum of endourologic and laparoscopic techniques. Two illustrative cases are described.